Review Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?

This publication has 30 references indexed in Scilit:

• Neuropsychological change in early phase schizophrenia over twelve months of treatment with olanzapine, risperidone, or haloperidol
  Schizophrenia Research, 1998
• Cost-effectiveness of clozapine
  The British Journal of Psychiatry, 1997
• Olanzapine
  Drugs, 1997
• The role of cognition in the risk‐benefit and safety analysis of antipsychotic medication
  Acta Psychiatrica Scandinavica, 1996
• P-15-1: Long-term safety of risperidone
  European Neuropsychopharmacology, 1996
• Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy
  Clinical Drug Investigation, 1996
• Oral versus depot administration of neuroleptics in relapse prevention
  Acta Psychiatrica Scandinavica, 1994
• Is There Cognitive Decline in Schizophrenia?
  The British Journal of Psychiatry, 1994
• The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia
  The British Journal of Psychiatry, 1993
• The effect of long‐term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years
  Acta Psychiatrica Scandinavica, 1988